CTKB — Cytek Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual balance sheet for Cytek Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	165	365	341	262	278
Net Total Accounts Receivable
Net Total Receivables	18.1	29.6	50.9	56.1	60.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	209	432	454	392	396
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.14	5.85	27.6	29.3	28.1
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	220	463	519	494	500
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	26.5	33.2	49	56.2	67.7
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	41.7	58.3	94.2	101	104
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	178	405	425	393	396
Total Liabilities & Shareholders' Equity	220	463	519	494	500
Total Common Shares Outstanding
Total Preferred Shares Outstanding